Endo/exo-proteolysis in neoplastic progression and metastasis

Journal of Molecular Medicine

Volumn 83, Issue 11, 2005, Pages 856-864

  Khatib, Abdel Majid ^a,b   Bassi, Daniel ^c   Siegfried, Geraldine ^a   Klein Szanto, Andres J P ^c   Ouafik, L'Houcine ^a,d  

^a INSERM   (France)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c FOX CHASE CANCER CENTER   (United States)

^d EMI 0359 Research Laboratory

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN PITTSBURGH; ALPHA 1 ANTITRYPSIN PORTLAND; ALPHA AMIDATING ENZYME; AMINO ACID; ANTIVIRUS AGENT; CELL ADHESION MOLECULE; CYSTINE; DECANOYLARGINYLVALYLLEUCYLARGINYL CHLOROMETHYL KETONE; GROWTH FACTOR RECEPTOR; GROWTH PROMOTOR; HEXA DEXTRO ARGININAMIDE; METALLOPROTEINASE; OVOMUCOID; PEPTIDE; POLYARGININE; PROTEIN PRECURSOR; PROTEINASE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

AMIDATION; ANTINEOPLASTIC ACTIVITY; AUTOCRINE EFFECT; CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER THERAPY; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL FUNCTION; CELL GROWTH; DRUG EFFECT; DRUG MECHANISM; ENZYME SUBSTRATE; EXTRACELLULAR MATRIX; GLIOBLASTOMA; HUMAN; LUNG CANCER; METASTASIS; NONHUMAN; PARACRINE SIGNALING; PROSTATE CANCER; PROTEIN DEGRADATION; PROTEIN ENGINEERING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; TUMOR CELL; TUMOR PROMOTION;

EID: 27744495784     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-005-0692-y     Document Type: Review

References (80)

1. Khatib AM, Siegfried G, Chrétien M, Metrakos P, Seidah NG (2002) Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy. Am J Pathol 160:1921-1935
2. Thomas G (2002) Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 10:753-766
3. Taylor NA, Van De Ven WJ, Creemers JW (2003) Curbing activation: proprotein convertases in homeostasis and pathology. FASEB J 10:1215-1227
4. Seidah NG, Chrétien M (1999) Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res 848:45-62
5. DeClerck YA (2000) Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. Eur J Cancer 36:1258-1268
6. Eipper BA, Stoffers DA, Mains RE (1992) The biosynthesis of neuropeptides: peptide α-amidation. Annu Rev Neurosci 15:57-85
7. Fricker LD (1998) Carboxypeptidase E. Annu Rev Physiol 50:309-321
8. Kato I, Yonekura H, Tajima M, Yanagi M, Yamamoto H, Okamoto H (1990) Two enzymes concerned in peptide hormone α-amidation are synthesized from a single mRNA. Biochem Biophys Res Commun 172:197-203
9. Ouafik L'H, Mattei MG, Giraud P, Oliver C, Eipper BA, Mains RE (1993) Localization of the gene encoding peptidylglycine alpha-amidating monooxygenase (PAM) to human chromosome 5q14-5q21. Genomics 18:319-321
10. Schalken JA, Roebroek AJ, Oomen PP, Wagenaar SS, Debruyne FM, Bloemers HP, Van de Ven WJ (1987) fur gene expression as a discriminating marker for small cell and non-small cell lung carcinomas. J Clin Invest 80(6):1545-1549
11. Creemers JW, Roebroek AJ, Van de Ven WJ (1992) Expression in human lung tumor cells of the proprotein processing enzyme PC1/PC3. Cloning and primary sequence of a 5 kb cDNA. FEBS Lett 300:82-88
12. Mbikay M, Sirois F, Yao J, Seidah NG, Chretien M (1997) Comparative analysis of expression of the proprotein convertases furin, PACE4, PC1 and PC2 in human lung tumours. Br J Cancer 75:1509-1514
13. Lopez de Cicco R, Bassi DE, Page R, Klein-Szanto AJ (2002) Furin expression in squamous cell carcinomas of the oral cavity and other sites evaluated by tissue microarray technology. Acta Odontol Latinoam 15:29-37
14. Bassi DE, Mahloogi H, Lopez De Cicco R, Klein-Szanto A (2003) Increased furin activity enhances the malignant phenotype of human head and neck cancer cells. Am J Pathol 160:439-447
15. Fu Y, Campbell EJ, Shepherd TG, Nachtigal MW (2003) Epigenetic regulation of proprotein convertase PACE4 gene expression in human ovarian cancer cells. Mol Cancer Res 1:569-576
16. Comperts B, Kramer I, Tatham P (2003) Signal transduction, chapter 8. Academic, San Diego
17. Dubois CM, Blanchette F, Laprise MH, Leduc R, Grondin F, Seidah NG (2001) Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. Am J Pathol 158:305-316
18. Constam DB, Robertson EJ (1999) Regulation of bone morphogenetic protein activity by prodomains and proprotein convertases. J Cell Biol 144:139-149
19. Pasche B (2001) Role of transforming growth factor beta in cancer. J Cell Physiol 186:153-168
20. Weeks BH, He W, Olson KL, Wang XJ (2001) Inducible expression of transforming growth factor beta1 in papillomas causes rapid metastasis. Cancer Res 61:7435-43
21. Siegfried G, Khatib AM, Benjannet S, Chretien M, Seidah NG (2003) The proteolytic processing of pro-platelet-derived growth factor-A at RRKR(86) by members of the proprotein convertase family is functionally correlated to platelet-derived growth factor-A-induced functions and tumorigenicity. Cancer Res 63:1458-1463
22. Siegfried G, Basak A, Cromlish JA, Benjannet S, Marcinkiewicz J, Chretien M, Seidah NG, Khatib AM (2003) The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest 111:1723-1732
23. Khatib AM, Siegfried G, Prat A, Luis J, Chretien M, Metrakos P, Seidah NG (2001) Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions. J Biol Chem 276:30686-30693
24. Santavicca M, Noel A, Angliker H, Stoll I, Segain JP, Anglard P, Chretien M, Seidah N, Basset P (1996) Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenyl-mercuric acetate and furin-type convertases. Biochem J 315:953-958
25. Pei D, Weiss SJ (1995) Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375:244-247
26. Yana I, Weiss SJ (2000) Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell 11:2387-2401
27. Loechel F, Gilpin BJ, Engvall E, Albrechtsen R, Wewer UM (1998) Human ADAM 12 (meltrin α) is an active metalloprotease. J Biol Chem 273:16993-16997
28. Kuno K, Kanada N, Nakashima E, Fujiki F, Ichimura F, Matsushima K (1997) Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene. J Biol Chem 272:556-562
29. Kuno K, Terashima Y, Matsushima K (1999) ADAMTS-1 is an active metalloproteinase associated with the extracellular matrix. J Biol Chem 274:18821-18826
30. Springer TA (1995) Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57:827-872
31. Carlos TM, Harlan JM (1994) Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101
32. Lehmann M, Rigot V, Seidah NG, Marvaldi J, Lissitzky JC (1996) Lack of integrin α-chain endoproteolytic cleavage in furin-deficient human colon adenocarcinoma cells LoVo. Biochem J 317:803-809
33. Lissitzky JC, Luis J, Munzer JS, Benjannet S, Parat F, Chretien M, Marvaldi J, Seidah NG (2000) Endoproteolytic processing of integrin pro-α subunits involves the redundant function of furin and proprotein convertase (PC) 5A, but not paired basic amino acid converting enzyme (PACE) 4, PC5B or PC7. Biochem J 346:133-138
34. Berthet V, Rigot V, Champion S, Secchi J, Fouchier F, Marvaldi J, Luis J (2000) Role of endoproteolytic processing in the adhesive and signaling functions of αvβ5 integrin. J Biol Chem 275:33308-33313
35. Bergeron E, Basak A, Decroly E, Seidah NG (2003) Processing of alpha4 integrin by the proprotein convertases: histidine at position P6 regulates cleavage. Biochem J 373:475-484
36. Tatemoto K, Mutt V (1978) Chemical determination of polypeptide hormones. Proc Natl Acad Sci U S A 75:4115-4119
37. Mains RE, Dickerson JM, May V, Stoffers DA, Perkins SN, Ouafik L'H, Husten EJ, Eipper BA (1990) Cellular and molecular aspects of peptide hormone biosynthesis. Front Neuroendocrinol 11:52-89
38. Satani M, Takahashi K, Sakamoto H, Harada S, Kaida Y, Noguchi M (2003) Expression and characterization of human bifunctional peptidylglycine alpha-amidating monooxygenase. Protein Expr Purif 28:293-302
39. Prigge ST, Mains RE, Eipper BA, Amzel LM (2000) New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell Mol Life Sci 57:1236-1259
40. Ouafik L'H, Stoffers DA, Campbell TA, Johnson RC, Bloomquist BI, Mains RE, Eipper BA (1992) The multifunctional peptidylglycine α-amidating monooxygenase gene: exon/intron organization of catalytic, processing and routing domains. Mol Endocrinol 6:1571-1584
41. Gether U, Aakerlund L, Schwartz TW (1991) Comparison of peptidylglycine α-amidation activity in medullary thyroid carcinoma cells, pheochromocytomas, and serum. Mol Cell Endocrinola 79:53-63
42. Maltese JY, Monge G, Giraud P, Salers P, Ouafik L'H, Pelen F, Oliver C (1990) Characterization of an α-amidating activity in a human pancreatic tumour secreting vasoactive intestinal peptide (VIP). Clin Endocrinol 33:467-480
43. Steel JH, Martinez A, Springall DR, Treston AM, Cuttitta F, Polak JM (1994) Peptidylglycine α-amidating monooxygenase (PAM) immunoreactivity and messenger RNA in human pituitary and increased expression in pituitary tumours. Cell Tissue Res 276:197-207
44. Scopsi L, Andreola S, Pilotti S, Bufalino R, Baldini MT, Testori A, Rilke F (1994) Mucinous carcinoma of the breast: a clinicopathological, histochemical, and immunocytochemical study with special reference to neuroendocrine differentiation. Am J Surg Pathol 18:702-711
45. Liu AY, Corey E, Bladou F, Lange PH, Vessela RL (1996) Prostatic cell lineage markers: emergence of Bcl2+ cells of human prostate cancer xenograft LuCaP 23 following castration. Int J Cancer 65:85-89
46. Rocchi P, Boudouresque F, Zamora AJ, Muracciole X, Lechevallier E, Martin PM, Ouafik L'H (2001) Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. Cancer Res 61:1196-1206
47. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T (1993) Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 194:720-725
48. Hinson JP, Kapas S, Smith DM (2000) Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21:138-167
49. Jimenez N, Abasolo I, Jongsma J, Calvo A, Garayoa M, van der Kwast TH, van Steenbrugge GJ, Montuenga LM (2003) Androgen-independent expression of adrenomedullin and peptidylglycine alpha-amidating monooxygenase in human prostatic carcinoma. Mol Carcinog 38:14-24
50. McKeehan WL, Adams PS, Rosser MP (1984) Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res 44:1998-2010
51. Jongsma J, Oomen MH, Noordzij MA, Romijn JC, van Der Kwast TH, Schroder FH, van Steenbrugge GJ (2000) Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines. Prostate 42:34-44
52. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Hittmair A, Zhang J, Thurnher M, Bartsch G, Klocker H (1996) Regulation of prostatic growth and function by peptide growth factors. Prostate 28:392-405
53. Ouafik L'H, Sauze S, Boudouresque F, Chinot O, Delfino C, Fina F, Vuaroqueaux V, Dussert C, Palmari J, Dufour H, Grisoli F, Casellas P, Brünner, Martin PM (2002) Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 160:1279-1292
54. Fernandez-Sauze S, Delfino C, Mabrouk K, Dussert C, Chinot O, Martin PM, Grisoli F, Ouafik L'H, Boudouresque F (2004) Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors. Int J Cancer 108:797-804
55. Zhao Y, Hague S, Manek S, Zhang L, Bicknell R, Rees MC (1998) PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a nonestrogenic mechanism in the human endometrium. Oncogene 16:409-415
56. Cuttitta F, Carney D, Mulshine J, Moody T, Fedorko J, Fischler A, Minna J (1985) Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer. Nature 316:823-826
57. Iwai N, Martinez A, Miller MJ, Vos M, Mulshine JL, Treston AM (1999) Autocrine growth loops dependent on peptidyl alpha-amidating enzyme as targets for novel tumor cell growth inhibitors. Lung Cancer 23:209-222
58. Sunday ME, Hua J, Dai HB, Nusrat A, Torday JS (1990) Bombesin increases fetal lung growth and maturation in utero and in organ culture. Am J Respir Cell Mol Biol 3:199-205
59. Willey JC, Lechner JF, Harris CC (1984) Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide are growth factors for normal human bronchial epithelial cells. Exp Cell Res 153:245-248
60. Zhou J, Chen J, Mokotoff M, Zhong R, Shultz LD, Ball ED (2003) Bombesin/gastrin-releasing peptide receptor: a potential target for antibody-mediated therapy of small cell lung cancer. Clin Cancer Res 9:4953-4960
61. Kelley MJ, Linnoila RI, Avis IL, Georgiadis MS, Cuttitta F, Mulshine JL, Johnson BE (1997) Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer. Chest 112:256-261
62. Chaudhry A, Carrasquillo JA, Avis IL, Shuke N, Reynolds JC, Bartholomew R, Larson SM, Cuttitta F, Johnson BE, Mulshine JL (1999) Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer. Clin Cancer Res 5:3385-3393
63. Iwai N, Martinez A, Miller MJ, Bos M, Mulshine JL, Treston AM (1999) Autocrine growth loops dependent on peptidyl α-amidating enzyme as targets for novel tumor cell growth inhibitors. Lung Cancer 23:209-222
64. Angliker H, Shaw E, Stone SR (1993) Synthesis of oligopeptide chloromethanes to investigate extended binding regions of proteinases: application to the interaction of fibrinogen with thrombin. Biochem J 292:261-266
65. Hallenberger S, Bosch V, Angliker H, Shaw E, Klenk HD, Garten W (1992) Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature 360:358-361
66. Anderson ED, Molloy SS, Jean F, Fei H, Shimamura S, Thomas G (2002) The ordered and compartment-specific autoproteolytic removal of the furin intramolecular chaperone is required for enzyme activation. J Biol Chem 277:12879-12890
67. Boudreault A, Gauthier D, Lazure C (1998) Proprotein convertase PC1/3-related peptides are potent slow tight-binding inhibitors of murine PC1/3 and Hfurin. J Biol Chem 273:31574-31580
68. Zhong M, Munzer JS, Basak A, Benjannet S, Mowla SJ, Decroly E, Chretien M, Seidah NG (1999) The prosegments of furin and PC7 as potent inhibitors of proprotein convertases. In vitro and ex vivo assessment of their efficacy and selectivity. J Biol Chem 274:33913-33920
69. Nour N, Basak A, Chretien M, Seidah NG (2003) Structure-function analysis of the prosegment of the proprotein convertase PC5A. J Biol Chem 278:2886-2895
70. Basak A, Lazure C (2003) Synthetic peptides derived from the prosegments of proprotein convertase 1/3 and furin are potent inhibitors of both enzymes. Biochem J 373:231-239
71. Sarac MS, Cameron A, Lindberg I (2002) The furin inhibitor hexa-D-arginine blocks the activation of Pseudomonas aeruginosa exotoxin A in vivo. Infect Immun 70:7136-7139
72. Kibler KV, Miyazato A, Yedavalli VS, Dayton AI, Jacobs BL, Dapolito G, Kim SJ, Jeang KT (2004) Polyarginine inhibits gp160 processing by furin and suppresses productive human immunodeficiency virus type 1 infection. J Biol Chem 279:49055-49063
73. Lu W, Zhang W, Molloy SS, Thomas G, Ryan K, Chiang Y, Anderson S, Laskowski M Jr (1993) Arg15-Lys17-Arg18 turkey ovomucoid third domain inhibits human furin. J Biol Chem 268:14583-14585
74. Brennan SO, Owen MC, Boswell DR, Lewis JH, Carrell RW (1984) Circulating proalbumin associated with a variant proteinase inhibitor. Biochim Biophys Acta 802:24-28
75. Jean F, Stella K, Thomas L, Liu G, Xiang Y, Reason AJ, Thomas G (1998) Alpha1-antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. Proc Natl Acad Sci U S A 95:7293-7298
76. Anderson ED, Thomas L, Hayflick JS, Thomas G (1993) Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant. J Biol Chem 268:24887-24891
77. Bassi DE, Lopez De Cicco R, Mahloogi H, Zucker S, Thomas G, Klein-Szanto AJ (2001) Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells. Proc Natl Acad Sci U S A 98:10326-10331
78. Mercapide J, Lopez De Cicco R, Bassi DE, Castresana JS, Thomas G, Klein-Szanto AJ (2002) Inhibition of furin-mediated processing results in suppression of astrocytoma cell growth and invasiveness. Clin Cancer Res 8:1740-1746
79. Uchida K, Chaudhary LR, Sugimura Y, Adkisson HD, Hruska KA (2003) Proprotein convertases regulate activity of prostate epithelial cell differentiation markers and are modulated in human prostate cancer cells. J Cell Biochem 88:394-399
80. Jean F, Thomas L, Molloy SS, Liu G, Jarvis MA, Nelson JA, Thomas G (2000) A protein-based therapeutic for human cytomegalovirus infection. Proc Natl Acad Sci U S A 97:2864-2869